Results of a phase I/II trial adding carmustine (300 mg/m2)...

Leukemia 2005 Vol. 20; Iss. 2

Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation

Comenzo, R L, Hassoun, H, Kewalramani, T, Klimek, V, Dhodapkar, M, Reich, L, Teruya-Feldstein, J, Fleisher, M, Filippa, D, Nimer, S D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Year:
2005
Language:
english
Pages:
5
DOI:
10.1038/sj.leu.2404003
File:
PDF, 128 KB
english, 2005
Conversion to is in progress
Conversion to is failed